- Home
- SOS vs EDSA Comparison
SOS vs EDSA Comparison
Compare SOS & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- EDSA
- Stock Information
- Founded
- SOS 2004
- EDSA 2015
- Country
- SOS China
- EDSA Canada
- Employees
- SOS N/A
- EDSA N/A
- Industry
- SOS Finance: Consumer Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- SOS Finance
- EDSA Health Care
- Exchange
- SOS Nasdaq
- EDSA Nasdaq
- Market Cap
- SOS 17.0M
- EDSA 13.8M
- IPO Year
- SOS 2017
- EDSA N/A
- Fundamental
- Price
- SOS $8.48
- EDSA $2.09
- Analyst Decision
- SOS
- EDSA Strong Buy
- Analyst Count
- SOS 0
- EDSA 2
- Target Price
- SOS N/A
- EDSA $13.00
- AVG Volume (30 Days)
- SOS 62.3K
- EDSA 13.1K
- Earning Date
- SOS 05-15-2025
- EDSA 08-08-2025
- Dividend Yield
- SOS N/A
- EDSA N/A
- EPS Growth
- SOS N/A
- EDSA N/A
- EPS
- SOS N/A
- EDSA N/A
- Revenue
- SOS $231,424,000.00
- EDSA N/A
- Revenue This Year
- SOS N/A
- EDSA N/A
- Revenue Next Year
- SOS N/A
- EDSA N/A
- P/E Ratio
- SOS N/A
- EDSA N/A
- Revenue Growth
- SOS 150.42
- EDSA N/A
- 52 Week Low
- SOS $4.04
- EDSA $1.55
- 52 Week High
- SOS $15.51
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- SOS 72.31
- EDSA 55.09
- Support Level
- SOS $6.06
- EDSA $2.03
- Resistance Level
- SOS $9.62
- EDSA $2.11
- Average True Range (ATR)
- SOS 0.62
- EDSA 0.10
- MACD
- SOS 0.29
- EDSA 0.01
- Stochastic Oscillator
- SOS 72.17
- EDSA 73.33
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.